Baikoussis Nikolaos G, Papakonstantinou Nikolaos A, Dedeilias Panagiotis, Argiriou Michalis, Apostolakis Efstratios, Koletsis Efstratios, Dougenis Dimitrios, Charitos Christos
Cardiac Surgery Department, General Hospital of Athens "Evangelismos'", Athens, Greece.
J BUON. 2015 Jul-Aug;20(4):1115-23.
Primary cardiac tumors are uncommon but not extremely rare. Cardiac tumors, mostly intracavitary, include benign and malignant tumors that arise from the endocardium, heart valves or myocardium. This retrospective study summarizes the experience of the Cardiac Surgery Departments of three tertiary Hospitals in this field, and particularly in cardiac myxomas, over the last 29 years. Herein, we present the results of cardiac tumors excision in relation to postoperative morbidity and mortality.
Between 1985 and 2014, 117 patients, aged from 16 to 82 years, underwent resection of a cardiac tumor.
Ninety one of the tumors (77.78%) were myxomas, 15 of them (12.82%) were other primary cardiac tumors, 7 of them (5.98%) were infra-diaphragmatic tumors and the remaining 4 tumors (3.42%) were benign intracavitary masses (thrombi). Patients operated on for a cardiac tumor had a 30-day mortality rate of 3.29%. Atrial fibrillation appeared in 21 out of 91 patients (23.07%) operated on for cardiac myxoma, while neurological complications were observed in 3 patients (3.29%). Re-exploration for bleeding was performed in 5 out of 91 cases (5.49%) and recurrence occurred in 4.39% of myxomas.
Despite being rare, primary cardiac tumors require open heart intervention soon after their diagnosis in order to prevent complications and achieve low mortality rates.
原发性心脏肿瘤并不常见,但也并非极其罕见。心脏肿瘤大多位于心腔内,包括起源于心内膜、心脏瓣膜或心肌的良性和恶性肿瘤。这项回顾性研究总结了三家三级医院心脏外科在该领域,特别是在心脏黏液瘤方面过去29年的经验。在此,我们展示了心脏肿瘤切除术后的发病率和死亡率结果。
1985年至2014年间,117例年龄在16至82岁之间的患者接受了心脏肿瘤切除术。
91例肿瘤(77.78%)为黏液瘤,15例(12.82%)为其他原发性心脏肿瘤,7例(5.98%)为膈下肿瘤,其余4例肿瘤(3.42%)为良性心腔内肿物(血栓)。接受心脏肿瘤手术的患者30天死亡率为3.29%。91例接受心脏黏液瘤手术的患者中有21例(23.07%)出现房颤,3例(3.29%)出现神经系统并发症。91例中有5例(5.49%)因出血进行了再次手术探查,黏液瘤复发率为4.39%。
尽管原发性心脏肿瘤罕见,但为预防并发症并实现低死亡率,诊断后需尽快进行心脏直视手术干预。